Terazosin Hydrochloride
- Product NDC
- 63629-1414
- 11-digit product format
- 636291414
- Labeler code
- 63629
- Product ID
- 63629-1414_73f4a6d7-345b-48da-b77c-b4c90d2ae8cc
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2004-12-20
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Terazosin Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TERAZOSIN HYDROCHLORIDE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | D32S14F082 |
| Rxcui | 313219 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 63629-1414-1 | 2021-01-06 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-2 | 2021-01-06 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-3 | 2021-01-06 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-4 | 2021-01-06 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-1 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-2 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-3 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
| 63629-1414-4 | 2019-10-29 | C162847 | 48780-1 | 960f7f55-c9ef-8e05-e053-dbdaa90a074a | TERAZOSIN CAPSULES, USP |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 63629-1414-1 | Terazosin Hydrochloride | 100 in 1 BOTTLE | CAPSULE | 100 | | 6 |
| 63629-1414-2 | Terazosin Hydrochloride | 30 in 1 BOTTLE | CAPSULE | 30 | | 6 |
| 63629-1414-3 | Terazosin Hydrochloride | 90 in 1 BOTTLE | CAPSULE | 90 | | 6 |
| 63629-1414-4 | Terazosin Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | | 6 |
DailyMed Socrata Ingredients#
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-1414-1 | 63629141401 | 100 CAPSULE in 1 BOTTLE (63629-1414-1) | 100 capsule | 2009-09-10 | 0000-00-00 | No | No | Current |
| 63629-1414-2 | 63629141402 | 30 CAPSULE in 1 BOTTLE (63629-1414-2) | 30 capsule | 2009-09-10 | 0000-00-00 | No | No | Current |
| 63629-1414-3 | 63629141403 | 90 CAPSULE in 1 BOTTLE (63629-1414-3) | 90 capsule | 2009-09-10 | 0000-00-00 | No | No | Current |
| 63629-1414-4 | 63629141404 | 60 CAPSULE in 1 BOTTLE (63629-1414-4) | 60 capsule | 2009-09-10 | 0000-00-00 | No | No | Current |